How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAbbreviations
Cerrar esta carpeta1 INTRODUCTION
Ver el documentoObjectives
Ver el documentoThe need for formularies
Ver el documentoWhat is a formulary?
Ver el documentoThe essential medicines concept
Ver el documentoThe WHO model list of essential medicines and the WHO model formulary
Abrir esta carpeta y ver su contenido2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Abrir esta carpeta y ver su contenido3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Abrir esta carpeta y ver su contenido4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Abrir esta carpeta y ver su contenido5 ADDITIONAL SOURCES OF INFORMATION
Abrir esta carpeta y ver su contenido6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Abrir esta carpeta y ver su contenido7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Abrir esta carpeta y ver su contenido8 EVALUATION
Abrir esta carpeta y ver su contenido9 REVIEW AND UPDATE
Ver el documentoREFERENCES
 

The need for formularies

Medicines play a crucial role in the prevention and treatment of diseases. When used correctly, they can offer simple and cost-effective solutions to many health problems. Today many people have little or no access to safe and effective drug therapies and may be at risk of serious health problems due to treatment with ineffective, poor quality products, or incorrect and irrational use of medicines.

Formularies can be useful tools in solving some of these problems of drug therapy as they can:

- provide impartial drug information to counteract biased promotional activities or fill the gap where access to accurate, and up-to-date information is limited;

- promote the appropriate use of safe, effective and good quality medicines;

- help in the elimination of unsafe, ineffective or poor quality medicinal products by identifying effective and safe medications; and

- support cost-effective utilization of drug budgets and improve access to essential medicines.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013